U.S. federal trademark · Serial No. 99926297
Research and development services in cellular DNA-encoded library drug discovery; research and development in cell-based ligand discovery and target identification; pharmaceutical drug discovery and development services; research and development in therapeutics discovery; research and development in small-molecule discovery using DNA-encoded libraries; research and development in cellular target engagement and compound validation; conducting cellular screening, affinity selection, hit identification, hit validation, and lead discovery for scientific and pharmaceutical research; technology research in therapeutics discovery and drug discovery platforms; pharmaceutical product development relating to small molecules, molecular glues, degraders, peptides, antibodies, and therapeutic modalities; research and development of therapeutic compounds targeting intracellular proteins, membrane proteins, protein complexes, transcription factors, and signaling proteins.
Reagents for cellular DNA-encoded library screening and selection; reagents for cellular ligand discovery assays; reagents for cell-based compound screening and target engagement assays; reagents for DNA-encoded library-based drug discovery; reagents for enrichment, identification, validation, and characterization of ligand-target interactions in cells; biochemical reagents for cellular screening assays; assay reagents for identifying bioactive compounds in living cells; reagents for affinity selection and molecular interaction analysis; nucleic acid-tagged chemical libraries; chemical preparations for scientific purposes; biochemical reagents for scientific use; proteins, enzymes, nucleic acids, and chemical reagents for scientific research use; diagnostic preparations for scientific and laboratory research use; reagents for therapeutics discovery and drug discovery research.
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.